Glutathione Injection
Product details
- Glutathione Injection
Company announcement
Greenwich Rx is voluntarily recalling specific lots of its compounded glutathione due to potential elevated endotoxin levels.
The product was distributed to patients nationwide between June 26, 2026, and September 21, 2026.
Two patients have reported receiving emergency department care following intravenous administration of a glutathione product not formulated for IV use.
Risk:
There is reasonable probability that injectable products with elevated endotoxin levels could cause significant medical events including fevers, hypotension, inflammatory reactions, anaphylactic shock and death. To date, Greenwich Rx has received two reports involving patients who received emergency department care following intravenous (IV) administration of a glutathione product that was not formulated for IV use.
Impacted states: Nationwide
Products:
- Glutathione Injection
- Glutathione Injection
- Glutathione Injection
- Glutathione Injection
- Glutathione Injection
- Glutathione Injection
- Glutathione Injection
- Glutathione Injection
- Glutathione Injection
- Glutathione Injection
Contact
For more information, call (866) 552-4916 or email GreenwichRx7542@sedgwick.com.
Related recalls
- Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) for Intravenous Infusion
- 0.9% Sodium Chloride Injection, USP, 100 mL
- Compounded Glutathione 200 mg/mL 30 mL multidose vial; Myer’s Cocktail 30 mL multidose vial; Tri-Immune Boost 30 mL multidose vial
- Luna G3 APAP (Model LG3600)
- 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container
- 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container